Skip to main content

RegMedNet is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Our journals
    • Our journals
    • Journal content
    • Journal articles

    Follow us on social media

  • Topics
    • CAR-T
      • Stem cells
      • Cell therapy
      • Gene therapy
      • Gene editing
    • Cancer
      • Preclinical research
      • Tissue engineering
      • 3D printing
      • Biobanking
    • Clinical trials & funding
      • Manufacturing & scale-up
      • Regulation & policy
      • Industry developments

    Follow us on social media

  • Explore content
    • News
      • The week in cell therapy
      • Interviews
      • Opinion
      • Report
      • App Notes & White Papers
    • Spotlights
      • In Focus
      • eBooks
      • Webinars
      • Podcasts
      • Videos
      • Infographics
    • Find a partner
      • Events
      • Events coverage
      • The Glossary for Advanced Therapies

    Follow us on social media

  • Register
Spotlight exclusive: Expert insights on GMP media, xeno-free solutions and raw material management Read the interview!

iPSC expansion in the Quantum Flex cell expansion system small bioreactor

28 Jan 2025
Written by Terumo BCT
App Notes & White Papers iPSCs Manufacturing & scale-up

Discover the efficiency and flexibility that can be achieved when expanding iPSCs in the Quantum Flex small bioreactor.

This poster is part of the RegMedNet In Focus on scaling iPSC cultures. Discover expert opinions on this topic by visiting our feature homepage.

iPSC Expansion_ Quantum Flex_ Summary Sheet


This content was provided by Terumo Blood and Cell Technologies.

Top content

  • Cell therapy weekly: BLA submission planned for Huntington’s gene therapy AMT-130
  • eBook | Viral and non-viral gene delivery approaches
  • Building a consortium to accelerate stem cell models for drug discovery

Related tags

Bioreactor cell expansion iPSCs Terumo BCT
Previous article Next article

Related articles

28 MAR 2025 IPSCS
eBook: Clinical applications of iPSCs
22 FEB 2022 INTERVIEWS
Professionalizing mesenchymal stem cells: an interview with Tony Ting
25 APR 2024 3D PRINTING
A promising eco-friendly candidate for bone tissue engineering
7 JAN 2025 IPSCS
GMP compliant iPSC lines and immune-oncology platform for allogeneic cell therapy
2 MAR 2021 NEWS
Autologous neuron transplants in monkeys provide hope for relieving Parkinson’s symptoms
10 OCT 2023 INTERVIEWS
Mimicking physiology with hollow-fiber perfusion technology: an interview with Mindy Miller
  • About
  • Advertising & Sponsorship
  • Expert Panel
  • Permissions & content ownership policy
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

RegMedNet is powered by Taylor & Francis Group

RegMedNet, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 RegMedNet